BioSpace News Archive

Offering was close to 5x oversubscribed; Issued under Genomma’s Recurring Debt Issuer Program

The offering is expected to close on September 16, 2019, subject to customary closing conditions.

The Milestones Program was established by IEEE in 1983 to honor significant achievements in the history of electrical and electronics engineering.

Sage Therapeutics, Inc. announced that on September 3, 2019, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 12,300 shares of its common stock, and 2,050 performance restricted stock units to four new employees under Sage’s 2016 Inducement Equity Plan.

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on September 4, 2019 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 48,750 shares of Puma common stock to five new non-executive employees.

The addition of Accountable Health Care will expand the Company’s capitated membership base and deepen its geographic footprint in Southern California.

A new study shows that a simple, non-invasive “contrast enhanced ultrasound” scan can be more accurate and reliable than a more expensive MRI procedure for diagnosis of liver tumors and determining whether they are cancerous.

As part of its Review of Operations, CannTrust reduces workforce and spend while preserving key talent

Parties have entered into a non-binding memorandum of understanding (“Memorandum”); a definitive agreement expected by the end of October 2019

These gas-filled bubbles, known as ultrasound contrast agents or enhancement agents, can help doctors detect “vulnerable plaque” in the carotid arteries leading to the brain.